Citadel Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Citadel Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,000	Closed	-$4.72K	–	15591
2023 Q2	$4.72K	Sell	31,000 -300	-1%	-$47	﹤0.01%	13573
2023 Q1	$4.49K	Sell	31,300 -84,400	-73%	-$13.5K	﹤0.01%	13951
2022 Q4	$13.9K	Sell	115,700 -2,900	-2%	-$418	﹤0.01%	13417
2022 Q3	$21K	Sell	118,600 -228,100	-66%	-$123K	﹤0.01%	12069
2022 Q2	$614K	Buy	346,700 +31,800	+10%	+$71.4K	﹤0.01%	8183
2022 Q1	$948K	Buy	314,900 +114,000	+57%	+$305K	﹤0.01%	7830
2021 Q4	$747K	Sell	200,900 -108,000	-35%	-$632K	﹤0.01%	8667
2021 Q3	$1.83M	Buy	308,900 +236,900	+329%	+$3.33M	﹤0.01%	6581
2021 Q2	$1.25M	Sell	72,000 -234,200	-76%	-$4.27M	﹤0.01%	7752
2021 Q1	$5.85M	Buy	306,200 +269,600	+737%	+$4.92M	﹤0.01%	3921
2020 Q4	$641K	Buy	+36,600	New	+$438K	﹤0.01%	7674

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Citadel Advisors's HGEN Position: Q3 2023 in Review

Citadel Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 24,586 shares — an estimated $3.75K sold.

Citadel Advisors first reported a position in HGEN in Q3 2020 and held it in 11 quarters. The position peaked at $14M in Q3 2020. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Citadel Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 24,586 HUMANIGEN, INC. shares in Q3 2023, an estimated $3.75K.
Citadel Advisors first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 11 quarters.
Citadel Advisors's HUMANIGEN, INC. position peaked at $14M in Q3 2020.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.